2025 MIDD Webinar Series | Harnessing QSP-based virtual populations to optimize novel oncology combination regimens: Antibody Drug Conjugates (ADC) and T Cell Engagers (TCE)

2025 MIDD Webinar Series | Harnessing QSP-based virtual populations to optimize novel oncology combination regimens: Antibody Drug Conjugates (ADC) and T Cell Engagers (TCE)

Includes a Live Web Event on 05/21/2025 at 12:00 PM (EDT)

The MIDD Webinar Series, coordinated by Yash Kapoor and Fulya Akpinar Singh, is a series of webinars focused on shaping the future of drug development and regulatory decision-making sponsored by the ISoP Education Committee. Topics range from MIDD approaches in regulatory submission to pharmacometrics topics that are at the core of model development.  

Yuezhe Li

Research Scientist II

Metrum Research Group

Yuezhe Li is a Research Scientist II at Metrum Research Group. Since joining Metrum Research Group in 2021, her work has focused on developing quantitative systems pharmacology (QSP) models to support preclinical and clinical development of antibody drug conjugates (ADCs), bispecific T cell engagers, and gene therapies. Yuezhe earned her Ph.D. in Biomedical Science from the University of Connecticut. Other fields of experiences include systems biology, machine learning, and mathematical modeling.

Key:

Complete
Failed
Available
Locked
MIDD Series | Harnessing QSP-based virtual populations to optimize novel oncology combination regimens: Antibody Drug Conjugates (ADC) and T Cell Engagers (TCE)
05/21/2025 at 12:00 PM (EDT)  |  60 minutes
05/21/2025 at 12:00 PM (EDT)  |  60 minutes